Skip to main content
    E

    Edesa Biotech Inc (EDSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.89
    -0.05 (-2.58%)

    Market Cap: $26.21M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Edesa Biotech Inc (EDSA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Edesa Biotech are Evaxion Biotech AS (EVAX), ImageneBio (IMA) and Estrella Immunopharma (ESLA). By market cap, Edesa Biotech ranks 7th of the 13 companies on this page; ImageneBio (IMA) is the largest at $43.22M.

    Peer Comparison

    EDSA's revenue growth of -99.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Edesa Biotech (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    Evaxion Biotech AS (EVAX)$25.27MN/A0.2x-115.5%-79.5%-100.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Lite Strategy, Inc. (LITS)$25.30MN/AN/A0.0%N/A0.0%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    Dare Bioscience Inc (DARE)$12.93MN/A6.4x0.0%N/A499.6%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Peer median$26.14MN/A4.3x0.0%-79.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Edesa Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Evaxion Biotech AS (EVAX)
    Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company...
    EVAX competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Lite Strategy, Inc. (LITS)
    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
    LITS competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    Dare Bioscience Inc (DARE)
    Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States.
    DARE competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.

    Frequently Asked Questions About EDSA

    Who are Edesa Biotech's main competitors?

    The companies most similar to Edesa Biotech include Evaxion Biotech AS (EVAX), ImageneBio (IMA), Estrella Immunopharma (ESLA), INmune Bio (INMB) and Lite Strategy (LITS), listed from the closest match.

    Who is Edesa Biotech's biggest competitor?

    ImageneBio (IMA) is the largest of the similar companies at $43.22M; Evaxion Biotech AS (EVAX) is the closest match by business profile, size, sector and industry.

    How does EDSA stock compare with its competitors?

    EDSA's net margin is 0.0% against a peer median of 0.0%.

    Which of Edesa Biotech's competitors pays a higher dividend?

    Edesa Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Edesa Biotech bigger than its competitors?

    No. Edesa Biotech is 7th by market cap among the 13 companies on this page; the largest is ImageneBio (IMA) at $43.22M.